Fiera Capital (Canada)
DYN icon

Fiera Capital (Canada)’s Dyne Therapeutics DYN Stock Holding History

Fiera Capital (Canada)’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5M Sell
789,989
-590,631
-43% -$11M 0.06% 179
2026
Q1 		$25M Buy
+1,380,620
New +$23.8M 0.09% 173

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fiera Capital (Canada)'s DYN Position: Q2 2026 in Review

Fiera Capital (Canada) reduced its Dyne Therapeutics (DYN) stake by 43% in Q2 2026, selling an estimated $11M and leaving 789,989 shares worth $17.5M. The position accounts for 0.06% of the portfolio, ranked #179.

Fiera Capital (Canada) first reported a position in DYN in Q1 2026 and has held it in 2 quarters since. The position peaked at $25M in Q1 2026. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Fiera Capital (Canada) held 789,989 shares of Dyne Therapeutics worth $17.5M as of Q2 2026.
  • Fiera Capital (Canada) sold 590,631 Dyne Therapeutics shares in Q2 2026, an estimated $11M.
  • Dyne Therapeutics made up 0.06% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #179 holding.
  • Fiera Capital (Canada) first reported a position in Dyne Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Fiera Capital (Canada)'s Dyne Therapeutics position peaked at $25M in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.